JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1998; 31:1260-1266
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartzman, R.
Right arrow Articles by Kaski, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartzman, R.
Right arrow Articles by Kaski, J.

Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectoris

RA Schwartzman, ID Cox, J Poloniecki, R Crook, CA Seymour, and JC Kaski

Department of Cardiological Sciences, St. George's Hospital Medical School, London, England, United Kingdom.

OBJECTIVES: We sought to assess the relation between plasma lipoprotein(a) [Lp(a)] levels, clinical variables and angiographic coronary artery disease (CAD) in patients with chronic stable angina. BACKGROUND: The relation between plasma Lp(a) levels and the severity and extent of angiographic CAD has not been studied in well characterized patients with stable angina pectoris. METHODS: We investigated clinical variables, lipid variables and angiographic scores in 129 consecutive white patients (43 women) undergoing coronary angiography for chronic stable angina. RESULTS: Plasma Lp(a) levels were significantly higher in patients with than in those without significant angiographic stenoses (> or =70%) (372 mg/liter [interquartile range 87 to 884] vs. 105 mg/liter [interquartile range 56 to 366], respectively, p=0.002). This difference remained significant when patients with mild or severe angiographic disease were compared with those with completely normal coronary arteries (312 mg/liter [interquartile range 64 to 864] vs. 116 mg/liter [interquartile range 63 to 366], respectively, p=0.02). However, subset analysis indicated that this difference achieved statistical significance only in women. Multiple logistic regression analysis indicated that Lp(a) concentration was independently predictive of significant angiographic stenoses (adjusted odds ratio [OR] 9.1, 95% confidence interval [CI] 2.0 to 42.1, p=0.006) and remained true even after exclusion of patients receiving lipid-lowering treatment (n=27) (OR 10.4, 95% CI 1.1 to 102.9, p=0.05). Lp(a) also had independent predictive value in a similar analysis using mild or severe angiographic disease as the outcome variable (OR 11.8, 95% CI 1.5 to 90.8, p=0.02). CONCLUSIONS: Our results indicate that elevated plasma Lp(a) is an independent risk factor for angiographic CAD in chronic stable angina and may have particular significance in women.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. Hartmann, C. von Birgelen, G. S. Mintz, M. G. Stoel, H. Eggebrecht, H. Wieneke, M. Fahy, T. Neumann, J. van der Palen, H. W. Louwerenburg, et al.
Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 446 - 452.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Cosin-Sales, M. Christiansen, P. Kaminski, C. Oxvig, M. T. Overgaard, D. Cole, D. W. Holt, and J. C. Kaski
Pregnancy-Associated Plasma Protein A and Its Endogenous Inhibitor, the Proform of Eosinophil Major Basic Protein (proMBP), Are Related to Complex Stenosis Morphology in Patients With Stable Angina Pectoris
Circulation, April 13, 2004; 109(14): 1724 - 1728.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Ricci, G. Tamaro, R. Simeone, E. Giolo, G. Nucera, F. De Seta, and S. Guaschino
Lipoprotein(a) changes during natural menstrual cycle and ovarian stimulation with recombinant and highly purified urinary FSH
Hum. Reprod., March 1, 2001; 16(3): 449 - 456.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
D. Tontsch, B. Noll, J. R. Schaefer, M. Herzum, B. Maisch, and B. Goeke
Hyperinsulinemia, Lipoprotein (a), and Chlamydia pneumoniae Antibodies--Are They Risk Factors or Serologic Predictors for Progression of Coronary Artery Disease?
Angiology, October 1, 2000; 51(10): 831 - 836.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
K. Miwa, K. Nakagawa, N. Yoshida, Y. Taguchi, and H. Inoue
Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm
J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1200 - 1205.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
X. Garcia-Moll, F. Coccolo, D. Cole, and J. C. Kaski
Serum neopterin and complex stenosis morphology in patients with unstable angina
J. Am. Coll. Cardiol., March 15, 2000; 35(4): 956 - 962.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Nishino, M. J. Malloy, J. Naya-Vigne, J. Russell, J. P. Kane, and R. F. Redberg
Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women
J. Am. Coll. Cardiol., February 1, 2000; 35(2): 314 - 320.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
B Jorgensen, S Simonsen, K Endresen, K Forfang, T Egeland, A.T Hostmark, and E Thaulow
Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids
Eur. Heart J., October 1, 1999; 20(19): 1407 - 1414.
[Abstract] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1998 by the American College of Cardiology Foundation.